1
|
Chen X, Zou C. Further delineation of phenotype and genotype of Kenny-Caffey syndrome type 2 (phenotype and genotype of KCS type 2). Mol Genet Genomic Med 2024; 12:e2433. [PMID: 38591167 PMCID: PMC11002637 DOI: 10.1002/mgg3.2433] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2023] [Revised: 02/10/2024] [Accepted: 03/19/2024] [Indexed: 04/10/2024] Open
Abstract
BACKGROUND Kenny-Caffey syndrome type 2 (KCS2) is an extremely rare inherited disorder characterized by proportionate short stature, skeletal defects, ocular and dental abnormalities, and transient hypocalcemia. It is caused by variants in FAM111A gene. Diagnosis of KCS2 can be challenging because of its similarities to other syndromes, the absence of clear hallmarks and the deficient number of genetically confirmed cases. Here, we aimed to further delineate and summarize the genotype and phenotype of KCS2, in order to get a better understanding of this rare disorder, and promote early diagnosis and intervention. METHODS We present clinical and genetic characteristics of eight newly affected individuals with KCS2 from six families, including one family with three individuals found to be a father-to-daughter transmission, adding to the limited literature. Furthermore, we performed a review of genetically confirmed KCS2 cases in PubMed, MEDLINE and CNKI databases. RESULTS There were six females and two males in our cohort. All the patients presented with short stature (100.0%). Clinical manifestations included ocular defects such as hypermetropia (5/8), dental problems such as defective dentition (3/8) and dental caries (3/8), skeletal and brain anomalies such as delayed closure of anterior fontanelle (6/8), cerebral calcification (3/8), cortical thickening (3/8) and medullary stenosis (4/8) of tubular bones. Endocrinologic abnormalities included hypoparathyroidism (5/8) and hypocalcemia (3/8). One male patient had micropenis and microorchidism. All cases harboured missense variants of FAM111A, and nucleotides c.1706 arose as a mutational hotspot, with seven individuals harbouring a c.1706G>A (p.Arg569His) variant, and one child harbouring a c.1531T>C (p.Tyr511His) variant. Literature review yielded a total of 46 patients from 20 papers. Data analysis showed that short stature, hypoparathyroidism and hypocalcemia, ocular and dental defects, skeletal features including cortical thickening and medullary stenosis of tubular bones, and seizures/spasms were present in more than 70% of the reported KCS2 cases. CONCLUSION We provide detailed characteristics of the largest KCS2 group in China and present the first genetically confirmed instance of father-to-daughter transmission of KCS2. Our study confirms that Arg569His is the hot spot variant and summarizes the typical phenotypes of KCS2, which would help early diagnosis and intervention.
Collapse
Affiliation(s)
- Xuefei Chen
- Department of Endocrinology, Children's HospitalZhejiang University School of MedicineHangzhouChina
| | - Chaochun Zou
- Department of Endocrinology, Children's HospitalZhejiang University School of MedicineHangzhouChina
| |
Collapse
|
2
|
Purushothama G, Bhavani GSL, Shah H, Girisha KM, Handattu K. Expansion of Phenotypic Spectrum in Hyperphosphatemic Familial Tumoral Calcinosis. Indian Pediatr 2024; 61:186-188. [PMID: 38217273] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2024]
Affiliation(s)
- Greeshma Purushothama
- Department of Medical Genetics, Kasturba Medical College, (Manipal Academy of Higher Education), Manipal, Karnataka
| | - Gandham Sri Lakshmi Bhavani
- Department of Medical Genetics, Kasturba Medical College, (Manipal Academy of Higher Education), Manipal, Karnataka
| | - Hitesh Shah
- Department of Pediatric Orthopedics, Kasturba Medical College, (Manipal Academy of Higher Education), Manipal, Karnataka
| | - Katta Mohan Girisha
- Department of Medical Genetics, Kasturba Medical College, (Manipal Academy of Higher Education), Manipal, Karnataka
| | - Koushik Handattu
- Department of Pediatrics, Kasturba Medical College, (Manipal Academy of Higher Education), Manipal, Karnataka.
| |
Collapse
|
3
|
Yap JYC, Lim JY, Bhatia A, Tan VKJ, Koo S, Nishimura G, Moosa S, Koh AL, Tan EC, Fong N, Jamuar SS. The IFITM5 Ser40Leu variant can manifest as prenatal Caffey disease. Am J Med Genet A 2024; 194:358-362. [PMID: 37799085 DOI: 10.1002/ajmg.a.63420] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2023] [Revised: 08/28/2023] [Accepted: 09/15/2023] [Indexed: 10/07/2023]
Abstract
We report on a female neonate with a clinico-radiological presentation in keeping with a lethal form of prenatal Caffey disease (PCH). She had antenatal and postnatal features of severely bowed long bones, small chest, diaphyseal hyperostosis and polyhydramnios and died shortly after birth. Initial testing excluded COL1A1-related PCH, as an OI gene panel, consisting of COL1A1, COL1A2, CRTAP, and P3H1 genes, was negative. Targeted sequencing using a gene panel was performed and a de novo heterozygous, likely pathogenic variant in IFITM5: c.119C > T(p.Ser40Leu) was identified, which was previously described to cause a severe form of progressively deforming osteogenesis imperfect (OI). To our knowledge, variants in IFITM5 have not been reported in infantile Caffey disease (ICH) or PCH. Given that the pathogenesis of PCH is largely unknown, we postulate that a subset of PCH may be associated with variants in IFITM5.
Collapse
Affiliation(s)
- Jia Ying Celeste Yap
- Nephrology Service, Department of Pediatrics, KK Women's and Children's Hospital, Singapore, Singapore
- Pediatric Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore
| | - Jiin Ying Lim
- Pediatric Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore
- Genetics Service, Department of Pediatrics, KK Women's and Children's Hospital, Singapore, Singapore
| | - Anju Bhatia
- Department of Maternal-Fetal Medicine, KK Women's and Children's Hospital, Singapore, Singapore
| | - Vic Khi June Tan
- Department of Maternal-Fetal Medicine, KK Women's and Children's Hospital, Singapore, Singapore
| | - Stephanie Koo
- Pediatric Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore
- KK Research Centre, KK Women's and Children's Hospital, Singapore, Singapore
| | - Gen Nishimura
- Department of Radiology, Musashino-Yowakai Hospital, Tokyo, Japan
| | - Shahida Moosa
- Faculty of Medicine and Health Sciences, Division of Molecular Biology and Human Genetics, Stellenbosch University, Cape Town, South Africa
- Department of Medical Genetics, Tygerberg Hospital, Cape Town, South Africa
| | - Ai Ling Koh
- Pediatric Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore
- Genetics Service, Department of Pediatrics, KK Women's and Children's Hospital, Singapore, Singapore
| | - Ene Choo Tan
- Pediatric Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore
- Department of Maternal-Fetal Medicine, KK Women's and Children's Hospital, Singapore, Singapore
| | - Nikki Fong
- Pediatric Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore
- Genetics Service, Department of Pediatrics, KK Women's and Children's Hospital, Singapore, Singapore
| | - Saumya Shekhar Jamuar
- Pediatric Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore
- Genetics Service, Department of Pediatrics, KK Women's and Children's Hospital, Singapore, Singapore
| |
Collapse
|
4
|
De Mattia G, Maffi M, Mosca M, Mazzantini M. LRP5 high bone mass (Worth-type autosomal dominant endosteal hyperostosis): case report and historical review of the literature. Arch Osteoporos 2023; 18:112. [PMID: 37659026 PMCID: PMC10474981 DOI: 10.1007/s11657-023-01319-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/10/2023] [Accepted: 08/07/2023] [Indexed: 09/05/2023]
Abstract
PURPOSE LRP5 high bone mass (HBM) is an autosomal dominant endosteal hyperostosis caused by mutations of the low-density lipoprotein receptor-related protein 5 (LRP5) gene. Alternative names included "autosomal dominant osteosclerosis" and "Worth disease." The aim of the paper is to provide an historical overview of a disorder whose literature is complicated and confusing due to the past use of several denominations and lack of reviews. METHODS We collected case reports of HBM with evidence of autosomal dominant transmission preceding the identification of the LRP5 mutations in 2002 (Worth-type endosteal hyperostosis) and cases of LRP5 HBM confirmed by genetic analysis since 2002. The prevalence of relevant clinical and laboratory findings was estimated. We described an affected woman with neurological manifestations. RESULTS A 44-year-old Caucasian woman with torus palatinus complained of headache, hypo-/anosmia, and complete mixed deafness. Dual-energy X-ray absorptiometry (DEXA) scan revealed elevated bone mass. The A242T mutation of the LRP5 gene was detected. Including the present case, 155 patients have been reported to date. Neurological involvement and increased serum alkaline phosphatase (ALP) were present in 19.4% and 3.7% of cases, respectively. Facial changes and torus palatinus were observed in 61% and 41% of cases, respectively. CONCLUSIONS We present the only historical review on Worth-type endosteal hyperostosis, now known as LRP5 HBM. Neurological manifestations, previously considered absent in the disease, affect 19.4% of the patients. Genetic analysis and appropriate denomination of LRP5 HBM are fundamental for diagnosis and to mitigate the confusion that has long characterized this disease.
Collapse
Affiliation(s)
- Giammarco De Mattia
- Rare Bone Diseases Clinic, Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
| | - Michele Maffi
- Rare Bone Diseases Clinic, Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
| | - Marta Mosca
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Via Roma, 67 -, 56126, Pisa, Italy
| | - Maurizio Mazzantini
- Rare Bone Diseases Clinic, Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
| |
Collapse
|
5
|
Pallone SG, Kunii IS, da Silva REC, Lazaretti-Castro M. Use of Teriparatide in Hyperphosphatemic Familial Tumor Calcinosis: Evaluating the Interaction Between FGF23 and PTH on the Phosphaturic Effect. Calcif Tissue Int 2022; 111:102-106. [PMID: 35338393 DOI: 10.1007/s00223-022-00969-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/05/2021] [Accepted: 03/09/2022] [Indexed: 11/02/2022]
Abstract
Hyperphosphatemic familial tumor calcinosis (HFTC) is a rare disease characterized by hyperphosphatemia and calcium and phosphorus crystal deposition. It occurs due to the loss of function of FGF23. Herein, we report a case of a 50-year-old woman diagnosed with HFTC (homozygous variant in the GALNT3 gene, c.803_804 C insertion) with a history of ectopic calcifications in the past 30 years. Laboratory tests on admission were as follows: phosphate (P) 7.1 mg/dL (Normal range (NR) 2.5-4.5 mg/dL), FGF23 c-terminal 2050 RU/mL (NR < 150 RU/mL), and intact FGF23 (iFGF23) 18.93 pg/mL (NR 12.0-69.0 pg/mL). Treatment with acetazolamide, sevelamer, and a phosphorus-restricted diet was started, but phosphatemia remained high and calcifications continued to progress. In an attempt to further decrease P, a 36-day cycle of teriparatide (TPTD) 20 mcg twice daily was added, decreasing P from 6.2 to 5.2 mg/dL and increasing the 1.25(OH)2 vitamin D by 34.2%. As urinalysis was not feasible at the end of the 36-day cycle, a second cycle was performed for another 28 days, producing a similar decrease in P (from 6.4 to 5.5 mg/mL) and an evident decrease in the rate of tubular reabsorption of P (from 97.2 to 85.3%), however, accompanied by a worrying increase in calciuria. The use of TPTD 20 mcg twice daily in a patient with genetic resistance to FGF23 (HFTC) was associated with consistent increase in phosphaturia and reduction in phosphatemia, in addition to an increase in calcitriol. The resulting hypercalciuria precludes the therapeutic use of TPTD in HFTC and suggests an important role of FGF23, not only in phosphate homeostasis but also in avoiding any excess of calcitriol.
Collapse
Affiliation(s)
- Sthefanie Giovanna Pallone
- Endocrinology Unit, Department of Medicine, Federal University of São Paulo (UNIFESP), São Paulo, SP, Brazil.
| | - Ilda Sizue Kunii
- Endocrinology Unit, Department of Medicine, Federal University of São Paulo (UNIFESP), São Paulo, SP, Brazil
| | - Renata Elen Costa da Silva
- Endocrinology Unit, Department of Medicine, Federal University of São Paulo (UNIFESP), São Paulo, SP, Brazil
| | - Marise Lazaretti-Castro
- Endocrinology Unit, Department of Medicine, Federal University of São Paulo (UNIFESP), São Paulo, SP, Brazil
| |
Collapse
|
6
|
Huang J, Cao LG, Zhang TR, Li SM, Meng QQ. Primary hyperphosphatemic tumoral calcinosis: a case report. Osteoporos Int 2022; 33:309-312. [PMID: 34245344 DOI: 10.1007/s00198-021-06056-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/01/2021] [Accepted: 06/29/2021] [Indexed: 11/26/2022]
Abstract
Tumoral calcinosis (TC) is a rare disease characterized by periarticular soft tissue calcification. Some cases were reported in Africa and the Middle East. We report an 11-year-old Chinese girl presenting with recurrent multiple subcutaneous masses around the right elbow and hip regions. Although we found abnormalities in FGF23, a protein associated with phosphate metabolism, no positive results were observed in gene sequencing and analysis. The imaging features, laboratory examination, and pathology results confirmed our diagnosis. By using oral phosphorus-lowering drugs (acetazolamide) combined with complete surgical excision, good results were achieved, and no recurrence was reported during the follow-up of 18 months. We report a case of primary hyperphosphatemic TC. The combined use of oral phosphorus-lowering drugs (acetazolamide) and complete surgical excision produced good results, and no recurrence was reported during the follow-up of 18 months.
Collapse
Affiliation(s)
- J Huang
- Department of Orthopedics, Guangzhou Red Cross Hospital, Jinan University, Guangzhou, China
| | - L-G Cao
- Department of Orthopedics, Guangzhou Red Cross Hospital, Jinan University, Guangzhou, China
| | - T-R Zhang
- Department of Orthopedics, Guangzhou Red Cross Hospital, Jinan University, Guangzhou, China
| | - S-M Li
- Department of Orthopedics, Guangzhou Red Cross Hospital, Jinan University, Guangzhou, China.
| | - Q-Q Meng
- Department of Orthopedics, Guangzhou Red Cross Hospital, Jinan University, Guangzhou, China.
| |
Collapse
|
7
|
Affiliation(s)
- C Yerawar
- Department of Biochemistry, Shree Narayana Institute of Medical Superspeciality, Nanded, Maharashtra 431602, India
| | - A Kabde
- Department of Biochemistry, Shree Narayana Institute of Medical Superspeciality, Nanded, Maharashtra 431602, India
| | - P Deokar
- Department of Biochemistry, Shree Narayana Institute of Medical Superspeciality, Nanded, Maharashtra 431602, India
| |
Collapse
|
8
|
Nie M, Oravcová M, Jami‐Alahmadi Y, Wohlschlegel JA, Lazzerini‐Denchi E, Boddy MN. FAM111A induces nuclear dysfunction in disease and viral restriction. EMBO Rep 2021; 22:e50803. [PMID: 33369867 PMCID: PMC7857424 DOI: 10.15252/embr.202050803] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2020] [Revised: 11/17/2020] [Accepted: 11/20/2020] [Indexed: 12/13/2022] Open
Abstract
Mutations in the nuclear trypsin-like serine protease FAM111A cause Kenny-Caffey syndrome (KCS2) with hypoparathyroidism and skeletal dysplasia or perinatally lethal osteocraniostenosis (OCS). In addition, FAM111A was identified as a restriction factor for certain host range mutants of the SV40 polyomavirus and VACV orthopoxvirus. However, because FAM111A function is poorly characterized, its roles in restricting viral replication and the etiology of KCS2 and OCS remain undefined. We find that FAM111A KCS2 and OCS patient mutants are hyperactive and cytotoxic, inducing apoptosis-like phenotypes such as disruption of nuclear structure and pore distribution, in a protease-dependent manner. Moreover, wild-type FAM111A activity causes similar nuclear phenotypes, including the loss of nuclear barrier function, when SV40 host range mutants attempt to replicate in restrictive cells. Interestingly, pan-caspase inhibitors do not block these FAM111A-induced phenotypes, implying it acts independently or upstream of caspases. In this regard, we identify nucleoporins and the associated GANP transcription/replication factor as FAM111A interactors and candidate targets. Overall, we reveal a potentially unifying mechanism through which deregulated FAM111A activity restricts viral replication and causes KCS2 and OCS.
Collapse
Affiliation(s)
- Minghua Nie
- Department of Molecular MedicineThe Scripps Research InstituteLa JollaCAUSA
| | - Martina Oravcová
- Department of Molecular MedicineThe Scripps Research InstituteLa JollaCAUSA
| | - Yasaman Jami‐Alahmadi
- Department of Biological ChemistryDavid Geffen School of MedicineUniversity of CaliforniaLos AngelesCAUSA
| | - James A Wohlschlegel
- Department of Biological ChemistryDavid Geffen School of MedicineUniversity of CaliforniaLos AngelesCAUSA
| | | | - Michael N Boddy
- Department of Molecular MedicineThe Scripps Research InstituteLa JollaCAUSA
| |
Collapse
|
9
|
Abstract
Congenital diseases that could result in hyperphosphatemia at an early age include hyperphosphatemic familial tumoral calcinosis (HFTC)/hyperostosis-hyperphosphatemia syndrome (HHS) and congenital hypoparathyroidism/pseudohypoparathyroidism due to the insufficient activity of fibroblast growth factor (FGF) 23 and parathyroid hormone. HFTC/HHS is a rare autosomal recessive disease caused by inactivating mutations in the FGF23, UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GALNT3), or Klotho (KL) genes, resulting in the excessive cleavage of active intact FGF23 (FGF23, GALNT3) or increased resistance to the action of FGF23 (KL). Massive ectopic calcification, known as tumoral calcinosis (TC), is seen in periarticular soft tissues, typically in the hip, elbow, and shoulder in HFTC/HHS, reducing the range of motion. However, other regions, such as the eye, intestine, vasculature, and testis, are also targets of ectopic calcification. The other symptoms of HFTC/HHS are painful hyperostosis of the lower legs, dental abnormalities, and systemic inflammation. Low phosphate diets, phosphate binders, and phosphaturic reagents such as acetazolamide are the treatment options for HFTC/HHS and have various consequences, which warrant the development of novel therapeutics involving recombinant FGF23.
Collapse
Affiliation(s)
- Nobuaki Ito
- Division of Nephrology and Endocrinology, The University of Tokyo Hospital, Tokyo, Japan.
| | - Seiji Fukumoto
- Fujii Memorial Institute of Medical Sciences, Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Japan
| |
Collapse
|
10
|
Liu C, Pang Q, Jiang Y, Xia Y, Fang L, Wang O, Li M, Xing X, Gong Y, Xia W. Defective O-glycosylation of novel FGF23 mutations in a Chinese family with hyperphosphatemic familial tumoral calcinosis. Bone 2020; 137:115401. [PMID: 32360901 DOI: 10.1016/j.bone.2020.115401] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/18/2019] [Revised: 03/25/2020] [Accepted: 04/28/2020] [Indexed: 11/21/2022]
Abstract
OBJECTIVES Hyperphosphatemic familial tumoral calcinosis/hyperostosis-hyperphosphatemia syndrome (HFTC/HHS) is a rare disorder caused by deficiency or resistance of fibroblast growth factor 23 (FGF23). Here we reported a Chinese family with HFTC/HHS, aiming at clarifying the clinical features, bone microarchitectures and molecular mechanisms of the disease. METHODS Clinical manifestations, laboratory examinations and genetic analyses were collected from two HFTC patients. Bone microarchitectures were detected by HR-pQCT. In vitro expression and glycosylation of mutant and wild-type FGF23 proteins were analyzed by western blotting and wheat germ agglutinin affinity chromatography. Subcellular localizations of FGF23 proteins were detected by immunocytochemistry. RESULTS The two brothers carried previously unreported c.413T > G, p.Leu138Arg and c.491T > A, p.Ile164Asn compound heterozygous variants in the FGF23 gene, which was "likely pathogenic" according to American College of Medical Genetics (ACMG) Standards and Guidelines. Both patients had severe hyperphosphatemia and significantly elevated C-terminal FGF23. With HHS, patient 1 presented with lower extremity pain and widespread cardiovascular calcification. HR-pQCT of his distal radius and tibia revealed decreased volume BMD and cortical thickness, which were inconsistent with hyperostosis manifestations in X-ray. He received etidronate treatment, which improved his BMD and the ectopic calcification. His brother exhibited less bone involvement but had experienced recurrent painful calcified mass from a young age and undergone several resections. In vitro experiments showed that the mutant FGF23 proteins had defective O-glycosylation and impaired secretion. However, no difference in subcellular localization was found between the wild-type and mutant FGF23 proteins. CONCLUSION We have presented a Chinese HFTC/HHS family with novel FGF23 c.413T > G, p.Leu138Arg and c.491T > A, p.Ile164Asn variants. We clarified the bone microarchitectures of HFTC/HHS patients by HR-pQCT, and expanded the genotype-phenotype spectrum of the disease. In vivo studies suggested that O-glycosylation of FGF23 plays an important role in the pathogenesis of HFTC/HHS, providing further understanding of the disease mechanism.
Collapse
Affiliation(s)
- Chang Liu
- Department of Endocrinology, NHC Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - Qianqian Pang
- Department of Endocrinology, NHC Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China; Musculoskeletal Research Laboratory and Bone Quality and Health Assessment Centre, Department of Orthopedics & Traumatology, The Chinese University of Hong Kong, Hong Kong
| | - Yan Jiang
- Department of Endocrinology, NHC Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - Yu Xia
- Department of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - Ligang Fang
- Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - Ou Wang
- Department of Endocrinology, NHC Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - Mei Li
- Department of Endocrinology, NHC Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - Xiaoping Xing
- Department of Endocrinology, NHC Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - Yiyi Gong
- Department of Endocrinology, NHC Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China; Central Research Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China.
| | - Weibo Xia
- Department of Endocrinology, NHC Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China.
| |
Collapse
|
11
|
|
12
|
|
13
|
Kawame H. [Cortical hyperostosis, infantile]. Ryoikibetsu Shokogun Shirizu 2001:496. [PMID: 11462534] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/16/2023]
Affiliation(s)
- H Kawame
- Division of Clinical and Molecular Genetics, Shinshu University Hospital
| |
Collapse
|
14
|
Femiano F, Cozzolino S, Malzone A. [Caffey's disease]. Arch Stomatol (Napoli) 1990; 31:599-601. [PMID: 2097976] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Caffey's disease or infantile cortical hyperostosis a rare condition affecting infants in the first five months of life. The disease begins usually as an acute febrile illness accompanied by painful swellings over one or more bones, with all the signs of acute inflammation.
Collapse
|
15
|
Kitagawa Y, Hirose G, Kosoegawa H, Kanda S, Hamada S. [A case of van Buchem's disease with multiple cranial neuropathy]. Rinsho Shinkeigaku 1986; 26:28-33. [PMID: 3516504] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
|
16
|
Meberg A. [Infantile cortical hyperostosis (morbus Caffey)]. Tidsskr Nor Laegeforen 1975; 95:1201-1. [PMID: 1099717] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
|
17
|
Marlet JJ. [The familial occurrence of cranial hyperostosis]. Ned Tijdschr Geneeskd 1972; 116:2333-7. [PMID: 4565698] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|
18
|
Sudjarwo SR, Tamaela LA, Karjomanggolo WT. Infantile cortical hyperostosis (a report of five cases). Paediatr Indones 1972; 12:308-20. [PMID: 4581981] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023] Open
|
19
|
Förster A. [Neonatal metaphyseal injuries: typical changes and an unusual site]. Ann Radiol (Paris) 1971; 14:315-20. [PMID: 4934810] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
20
|
Weis RW, Lewis TM. Infantile cortical hyperostosis: a study to determine if residual deformities exist in mandibles. ASDC J Dent Child 1969; 36:441-5. [PMID: 4900334] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
|
21
|
Levin S, Friedman J. Infantile cortical hyperostosis (Caffey's disease). S Afr Med J 1969; 43:972. [PMID: 4898163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023] Open
|
22
|
Mensi E. [Infantile cortical hyperostosis (Caffey-de Toni-Silverman disease)]. Minerva Nipiol 1968; 18:Suppl 6:247+. [PMID: 4910413] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
23
|
Ulloa JJ. [Hyperostosis of the mandible. Torus mandibularis]. Rev Asoc Odontol Costa Rica 1968; 3:29-35. [PMID: 4881466] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
|
24
|
Higure M, Takeuchi K, Hiyodo Y, Yanasisawa M. [Caffey's disease--report of 3 cases]. Nihon Shonika Gakkai Zasshi 1968; 72:9-15. [PMID: 4876721] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
|
25
|
Schmid F. [Taxonomy of dysostoses]. Radiologe 1967; 7:365-76. [PMID: 4968714] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
26
|
Kameneva TI, Trofimova ZA. [Congenital systemic diaphysial hyperostoses in children]. Vopr Okhr Materin Det 1966; 11:89-91. [PMID: 4871136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
|
27
|
Dobronravov AV. [Infantile cortical hyperostosis in a newborn infant]. Vopr Okhr Materin Det 1966; 11:82-4. [PMID: 4865106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
|
28
|
|
29
|
Ishige S. [2 cases of hyperostosis generalisata]. Seikei Geka 1966; 17:30-9. [PMID: 5335683] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
30
|
Rossi E, Grassi E. [Casuistic contribution to the knowledge of Caffey-de Toni-Silverman disease (infantile cortical hyperostosis)]. Minerva Radiol 1966; 11:40-7. [PMID: 5325546] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
31
|
Horansky V, Durco J. [A rare case of infantile cortical hyperostosis in a premature binovular twin]. Kinderarztl Prax 1965; 33:347-53. [PMID: 5320474] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
32
|
Shah PM, Sathe CH, Shah KP. Unilateral infantile cortical hyperostosis. Indian J Pediatr 1965; 32:227-32. [PMID: 5319137 DOI: 10.1007/bf02756515] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
33
|
RINONAPOLI F. [CONTRIBUTION TO THE STUDY OF INFANTILE CORTICAL HYPEROSTOSIS]. Rass Int Stomatol Prat 1965; 16:215-22. [PMID: 14316452] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/26/2023]
|
34
|
SPINDELL E, ORSON J. INFANTILE CORTICAL HYPEROSTOSIS: A CASE REPORT. R I Med J 1965; 48:134-5. [PMID: 14265477] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/26/2023]
|
35
|
TRACA G, HENNEBERT PN, MAZABRAUD A. [CONSIDERATIONS ON A CASE OF LIPOCALCINOGRANULOMATOSIS]. Presse Med (1893) 1965; 73:543-6. [PMID: 14243493] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/26/2023]
|
36
|
|
37
|
|
38
|
FANCONI G, MOREIRA G, UEHLINGER E, GIEDION A. [OSTEOCHALASIA DESMALIS FAMILIARIS. (HYPEROSTOSIS CORTICALIS DEFORMANS JUVENILIS, CHRONIC IDIOPATHIC HYPERPHOSPHATASIA, OSTEOECTASIA AND MACROCRANIUM)]. Helv Paediatr Acta 1964; 19:279-95. [PMID: 14229908] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/25/2023]
|
39
|
BONOMO B, CAVALERI E, LUCCHINETTI R. [THE CAFFEY-DE TONI-SILVERMAN SYNDROME. PRESENTATION OF A CASE]. Minerva Med 1964; 55:2315-9. [PMID: 14181815] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/25/2023]
|
40
|
ITATSU M, KOBYASHI K. [CASE OF HYPEROSTOSIS GENERALISATA]. Rinsho Hoshasen 1964; 9:562-70. [PMID: 14197555] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/25/2023]
|
41
|
REAVIS CW, GRIME H. INFANTILE CORTICAL HYPEROSTOSIS. J Tenn Med Assoc 1964; 57:293-5. [PMID: 14177096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/25/2023]
|
42
|
KNITTER T, KOZLOWSKI K. [A CASE OF A CONGENITAL FORM OF CORTICAL HYPEROSTOSIS IN AN INFANT (HYPEPOSTOSIS CORTICALIS INFANTUM)]. Pediatr Pol 1964; 39:461-4. [PMID: 14184224] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/25/2023]
|
43
|
KNITTER T, KOZLOWSKI K. [HYPEROSTOSIS CORTICALIS INFANTUM (CORTICAL HYPEROSTOSIS IN INFANTS)]. Pediatr Pol 1964; 39:465-72. [PMID: 14184225] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/25/2023]
|
44
|
MORILLO G, SABOGAL E, MELO D. [INFANTILE CORTICAL HYPEROSTOSIS OR CAFFEY-DE TONI DISEASE. PRESENTATION OF 2 CASES SEEN IN COLOMBIA AND REVIEW OF THE LITERATURE]. Rev Soc Colomb Pediatr Pueric 1964; 6:287-316. [PMID: 14153057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/25/2023]
|
45
|
BELIAEVA AA. [ON LIPOCALCINOGRANULOMATOSIS]. Ortop Travmatol Protez 1964; 25:74-7. [PMID: 14175365] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/25/2023]
|
46
|
CYPRESS GC. INFANTILE CORTICAL HYPEROSTOSIS (CAFFEY-SMYTH SYNDROME). J Natl Med Assoc 1964; 56:124-6. [PMID: 14129745 PMCID: PMC2610920] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/25/2023]
|
47
|
ARTEMIUK AG, GUREVICH MA. [MULTIPLE NEOPLASTIC LIPOCALCINOGRANULOMATOSIS]. Klin Med (Mosk) 1963; 41:115-9. [PMID: 14148107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/25/2023]
|
48
|
ABRAKHANOVA KN. [DYNAMICS OF THE ROENTGENOLOGICAL CHANGES IN THE BONES OF CHILDREN IN COOLEY'S CONGENITAL FAMILIAL HEMOLYTIC ANEMIA]. Vestn Rentgenol Radiol 1963; 38:18-23. [PMID: 14141357] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/25/2023]
|
49
|
KANWAR K, RAO PL, KUMARI S. INFANTILE CORTICAL HYPEROSTOSIS:(CHRONIC FORM). REPORT OF A CASE. Indian J Child Health 1963; 12:713-7. [PMID: 14080700] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/25/2023]
|
50
|
KUBICZ S, LODZINSKI K. [CORTICAL HYPEROSTOSIS SYNDROME IN A 3-MONTH-OLD INFANT]. Pol Przegl Radiol Med Nukl 1963; 27:375-80. [PMID: 14194566] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/25/2023]
|